HKEx Stock Code: 01093English|繁體|简体
Financial Summary
  For the year ended 31 December
  2011
HK$'000
(Note)
2012
HK$'000
2013
HK$'000
2014
HK$'000
2015
HK$'000
Results          
Revenue 2,407,445 4,146,444 9,949,103 10,955,077 11,393,726
Cost of sales (1,370,535) (2,341,104) (6,816,042) (6,767,724) (6,172,848)
           
Gross profit 1,036,910 1,805,340 3,133,061 4,187,353 5,220,878
Other income 28,010 38,693 211,402 134,558 86,561
Selling and distribution expenses (452,844) (757,297) (1,300,739) (1,788,032) (2,266,958)
Administrative expenses (138,325) (235,363) (620,291) (551,697) (534,881)
Other expenses (31,140) (87,797) (243,455) (307,814) (339,147)
           
Operating profit 442,611 763,576 1,179,978 1,674,368 2,166,453
Finance costs (21,705) (60,090) (72,537) (54,358) (56,335)
Share of results of          
   — an associate 375 141
   — a joint venture (3,981) (14,045) 588 10,663
Loss on disposal of an associate (8,873)
Gain on disposal of subsidiaries 154,228 511
Recognition of fair values of financial          
   guarantee contracts issued (17,676) (5,130)
Amortisation of financial          
   guarantee liabilities 14,908 18,485
Changes in fair value of          
   convertible bonds (222,739)
Gain on bargain purchase 1,810,702
           
Profit before tax 418,138 2,300,823 1,247,624 1,621,484 2,112,049
Income tax expense (60,964) (131,975) (258,324) (337,153) (432,423)
           
Profit for the year 357,174 2,168,848 989,300 1,284,331 1,679,626
           
Profit for the year attributable to:          
Owners of the Company 355,411 2,162,235 972,751 1,268,446 1,665,271
Non-controlling interests 1,763 6,613 16,549 15,885 14,355
         
  357,174 2,168,848 989,300 1,284,331 1,679,626
           
  HK cents
(Note)
HK cents HK cents HK cents HK cents
Earnings per share          
Basic N/A 147.78 17.49 21.47 28.18
           
Diluted N/A 52.04 16.54 21.26 27.95



  As at 31 December
  2011
HK$'000
(Note)
2012
HK$'000
2013
HK$'000
2014
HK$'000
2015
HK$'000
Assets and liabilities          
Total assets 2,408,914 13,698,711 12,200,547 12,501,230 13,539,851
Total liabilities (1,447,962) (6,934,966) (4,603,747) (4,349,702) (4,727,244)
         
Net assets >960,952 6,763,745 7,596,800 8,151,528 8,812,607
         
Equity attributable to owners of          
   the Company 949,379 6,586,760 7,452,620 8,079,154 8,738,055
Non-controlling interests 11,573 176,985 144,180 72,374 74,552
         
Total equity 960,952 6,763,745 7,596,800 8,151,528 8,812,607



Note:

The summary of the consolidated results of the Group for the year ended 31 December 2011, and of the consolidated assets and liabilities as at 31 December 2011, have been extracted from the Company’s Circular dated 26 September 2012. Such summary was prepared on the merger basis as if the current structure of the Group had been in existence throughout these financial years. No earnings per share information is presented for the year ended 31 December 2011 as its inclusion, for the purpose of this report, is not considered meaningful.

© Copyright 2017 CSPC Pharmaceutical Group Limited. All Rights Reserved.